Drug
GK01 injection
GK01 injection is a pharmaceutical drug with 5 clinical trials. Currently 3 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(60%)
Phase Distribution
Ph early_phase_1
2
40%
Ph phase_1
3
60%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
2(40.0%)
Phase 1Safety & dosage
3(60.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(5)
Detailed Status
Recruiting3
Not yet recruiting2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Early Phase 12 (40.0%)
Phase 13 (60.0%)
Trials by Status
recruiting360%
not_yet_recruiting240%
Recent Activity
3 active trials
Showing 5 of 5
not_yet_recruitingphase_1
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
NCT07482319
not_yet_recruitingearly_phase_1
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
NCT07412665
recruitingearly_phase_1
A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
NCT07414316
recruitingphase_1
A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
NCT07351903
recruitingphase_1
A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor
NCT06954558
Clinical Trials (5)
Showing 5 of 5 trials
NCT07482319Phase 1
A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors
NCT07412665Early Phase 1
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
NCT07414316Early Phase 1
A Single-Arm, Open-Label Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
NCT07351903Phase 1
A Single-arm, Open-label Study of GK01 in Combination With or Without Chemotherapy for the Adjuvant Treatment of Solid Tumors
NCT06954558Phase 1
A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5